Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.120 Biomarker disease BEFREE There were characteristic clinical features such as hypotonia and optic atrophy for SCA1; hyporeflexia for SCA2; nystagmus, bulging eye, and dystonia for SCA3; and macular degeneration for SCA7. 12810491 2003
Entrez Id: 778
Gene Symbol: CACNA1F
CACNA1F
0.120 GeneticVariation disease BEFREE Congenital stationary night blindess-2 (incomplete congenital stationary night blindness (iCSNB) or CSNB-2) is a nonprogressive, X-linked retinal disease which can lead to clinical symptoms such as myopia, hyperopia, nystagmus, strabismus, decreased visual acuity, and impaired scotopic vision. 17949918 2007
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.120 Biomarker disease HPO
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.120 Biomarker disease BEFREE Slow saccades and decreased deep tendon reflexes were observed significantly more frequently in SCA2 patients, while increased deep tendon reflexes and nystagmus were more common in SCA1. 10399872 1999
Entrez Id: 219285
Gene Symbol: SAMD9L
SAMD9L
0.110 Biomarker disease HPO
Entrez Id: 6576
Gene Symbol: SLC25A1
SLC25A1
0.110 Biomarker disease HPO
Entrez Id: 26504
Gene Symbol: CNNM4
CNNM4
0.110 Biomarker disease HPO
Entrez Id: 3913
Gene Symbol: LAMB2
LAMB2
0.110 Biomarker disease HPO
Entrez Id: 3000
Gene Symbol: GUCY2D
GUCY2D
0.110 Biomarker disease HPO
Entrez Id: 5961
Gene Symbol: PRPH2
PRPH2
0.110 Biomarker disease HPO
Entrez Id: 3000
Gene Symbol: GUCY2D
GUCY2D
0.110 GeneticVariation disease BEFREE Individuals affected with LCA are diagnosed at birth or in the first few months of life with severely impaired vision or blindness, nystagmus and an abnormal or flat electroretinogram (ERG).Mutations in GUCY2D (ref.3), RPE65 (ref.4) and CRX (ref. 10615133 2000
Entrez Id: 167691
Gene Symbol: LCA5
LCA5
0.110 GeneticVariation disease BEFREE All patients carrying LCA5 mutations presented nystagmus, night blindness, and progressive loss of visual acuity and visual field leading to blindness toward the third decade of life. 24144451 2014
Entrez Id: 6576
Gene Symbol: SLC25A1
SLC25A1
0.110 Biomarker disease BEFREE The characteristic clinical features in the earlier tested cases were nystagmus and fistula sign in CTP test-positive cases in category 1, and streaming water-like tinnitus in those in categories 2, 3 and 4. 28368720 2017
Entrez Id: 196
Gene Symbol: AHR
AHR
0.110 Biomarker disease HPO
Entrez Id: 5428
Gene Symbol: POLG
POLG
0.110 Biomarker disease HPO
Entrez Id: 219285
Gene Symbol: SAMD9L
SAMD9L
0.110 GeneticVariation disease BEFREE SAMD9L mutations have been reported in a few families with balance problems and nystagmus due to cerebellar atrophy, and may lead to similar hematological disease as seen in SAMD9 mutation carriers, from early childhood to adult years. 29535429 2018
Entrez Id: 1406
Gene Symbol: CRX
CRX
0.110 Biomarker disease HPO
Entrez Id: 4541
Gene Symbol: ND6
ND6
0.110 GeneticVariation disease BEFREE Three patients had previously identified mutations in mtDNA that are associated with optic neuropathy (in MT-ND6 and MT-ND1) and nystagmus (in tRNA Arg). 26448634 2016
Entrez Id: 1261
Gene Symbol: CNGA3
CNGA3
0.110 GeneticVariation disease BEFREE Mutations in the CNGA3 gene have been associated with complete and incomplete forms of total colour blindness (achromatopsia), a disorder characterized by reduced visual acuity, lack of colour discrimination, photophobia and nystagmus. 18445228 2008
Entrez Id: 4976
Gene Symbol: OPA1
OPA1
0.110 Biomarker disease HPO
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.110 Biomarker disease BEFREE Clinical features of SCA28 include slow to moderate progressive ataxia, dysarthria, and additional symptoms such as nystagmus, slow saccades, and increased deep tendon reflexes. 24293060 2014
Entrez Id: 4308
Gene Symbol: TRPM1
TRPM1
0.110 Biomarker disease BEFREE Children with TRPM1-associated cCSNB presented before school age with progressive myopia as well as strabismus and nystagmus (but not nyctalopia), with stable, electronegative ffERG results, mildly subnormal full-field stimulus threshold testing results, and a constricted I2e isopter on perimetry. 29522070 2018
Entrez Id: 492
Gene Symbol: ATP2B3
ATP2B3
0.110 Biomarker disease HPO
Entrez Id: 8842
Gene Symbol: PROM1
PROM1
0.110 Biomarker disease HPO
Entrez Id: 8398
Gene Symbol: PLA2G6
PLA2G6
0.110 Biomarker disease HPO